Gene · 3549
Papers2,936
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 2,936
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of Enhancers in Development and Diseases. | Epigenomes | 2021 | 34968246 | PubTator, text mining | PubMed |
| Using drug scheduling to manage adverse events associated with hedgehog pathway inhibitors for basal cell carcinoma. | Oncotarget | 2021 | 34966484 | PubTator, text mining | PubMed |
| Role of aberrant Sonic hedgehog signaling pathway in cancers and developmental anomalies. | J Biomed Res | 2021 | 34963676 | PubTator, text mining | PubMed |
| In Vitro Study of Licorice on IL-1β-Induced Chondrocytes and In Silico Approach for Osteoarthritis. | Pharmaceuticals (Basel) | 2021 | 34959737 | PubTator, text mining | PubMed |
| Modulation of Hair Growth Promoting Effect by Natural Products. | Pharmaceutics | 2021 | 34959442 | PubTator, text mining | PubMed |
| Nanoparticle-Based RNAi Therapeutics Targeting Cancer Stem Cells: Update and Prospective. | Pharmaceutics | 2021 | 34959397 | PubTator, text mining | PubMed |
| The Role of Hedgehog Pathway in Uterine Leiomyosarcoma. | J Cell Sci Ther | 2021 | 34956733 | PubTator, text mining | PubMed |
| Hereditary Multiple Exostoses-A Review of the Molecular Background, Diagnostics, and Potential Therapeutic Strategies. | Front Genet | 2021 | 34956317 | PubTator, text mining | PubMed |
| Indoleamine 2, 3 Dioxygenase 1 Impairs Chondrogenic Differentiation of Mesenchymal Stem Cells in the Joint of Osteoarthritis Mice Model. | Front Immunol | 2021 | 34956209 | PubTator, text mining | PubMed |
| Epstein-Barr Virus Epithelial Cancers-A Comprehensive Understanding to Drive Novel Therapies. | Front Immunol | 2021 | 34956172 | PubTator, text mining | PubMed |
| Regulation of Hedgehog Signal Transduction by Ubiquitination and Deubiquitination. | Int J Mol Sci | 2021 | 34948134 | PubTator, text mining | PubMed |
| Plant Derived Bioactive Compounds, Their Anti-Cancer Effects and In Silico Approaches as an Alternative Target Treatment Strategy for Breast Cancer: An Updated Overview. | Cancers (Basel) | 2021 | 34944840 | PubTator, text mining | PubMed |
| A Synopsis of Signaling Crosstalk of Pericytes and Endothelial Cells in Salivary Gland. | Dent J (Basel) | 2021 | 34940041 | PubTator, text mining | PubMed |
| Metabolic Pathways and Targets in Chondrosarcoma. | Front Oncol | 2021 | 34938658 | PubTator, text mining | PubMed |
TMEM165 a new player in proteoglycan synthesis: loss of TMEM165 impairs elongation of chondroitin- and heparan-sulfate glycosaminoglycan chains of proteoglycans and triggers early chondrocyte differentiation and hypertrophy. | Cell Death Dis | 2021 | 34930890 | PubTator, text mining | PubMed |
| Novel Pathways for Targeting Tumor Angiogenesis in Metastatic Breast Cancer. | Front Oncol | 2021 | 34926282 | PubTator, text mining | PubMed |
| Altered microRNAs in C3H10T1/2 cells induced by p.E95K mutant IHH signaling. | Hereditas | 2021 | 34922634 | PubTator, text mining | PubMed |
| Proteoglycans and Glycosaminoglycans in Stem Cell Homeostasis and Bone Tissue Regeneration. | Front Cell Dev Biol | 2021 | 34917612 | PubTator, text mining | PubMed |
| Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: protocol for a phase 2, randomised, double-blind, placebo-controlled trial. | BMJ Open | 2021 | 34916328 | PubTator, text mining | PubMed |
| Molecular Bases of Human Malformation Syndromes Involving the SHH Pathway: GLIA/R Balance and Cardinal Phenotypes. | Int J Mol Sci | 2021 | 34884862 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3549/papers?page=34